Showing 1 - 8 results of 8 for search 'Konstantinos A. Kyritsis', query time: 0.03s Refine Results
  1. 1
    Software pipelines for RNA-Seq, ChIP-Seq and germline variant calling analyses in common workflow language (CWL)

    Software pipelines for RNA-Seq, ChIP-Seq and germline variant calling analyses in common workflow language (CWL) by Konstantinos A. Kyritsis, Nikolaos Pechlivanis, Nikolaos Pechlivanis, Fotis Psomopoulos

    Published 2023-11-01
    Get full text
    Article
  2. 2
    Pharmacogenomic Testing to Guide Personalized Cancer Medicine Decisions in Private Oncology Practice: A Case Study

    Pharmacogenomic Testing to Guide Personalized Cancer Medicine Decisions in Private Oncology Practice: A Case Study by George Astras, Christos I. Papagiannopoulos, Konstantinos A. Kyritsis, Constantina Markitani, Ioannis S. Vizirianakis

    Published 2020-04-01
    Get full text
    Article
  3. 3
    Data on the expression of SRPK1a in mammals

    Data on the expression of SRPK1a in mammals by Metaxia Vlassi, Konstantinos A. Kyritsis, Ioannis S. Vizirianakis, Thomas Giannakouros, Michalis Aivaliotis, Eleni Nikolakaki

    Published 2019-08-01
    Get full text
    Article
  4. 4
    The histone methyltransferase inhibitor A-366 enhances hemoglobin expression in erythroleukemia cells upon co‐exposure with chemical inducers in culture

    The histone methyltransferase inhibitor A-366 enhances hemoglobin expression in erythroleukemia cells upon co‐exposure with chemical inducers in culture by Christos I. Papagiannopoulos, Nikoleta F. Theodoroula, Konstantinos A. Kyritsis, Melpomeni G. Akrivou, Maria Kosmidou, Konstantina Tsouderou, Nikolaos Grigoriadis, Ioannis S. Vizirianakis

    Published 2021-01-01
    Get full text
    Article
  5. 5
    Dissecting miRNA–Gene Networks to Map Clinical Utility Roads of Pharmacogenomics-Guided Therapeutic Decisions in Cardiovascular Precision Medicine

    Dissecting miRNA–Gene Networks to Map Clinical Utility Roads of Pharmacogenomics-Guided Therapeutic Decisions in Cardiovascular Precision Medicine by Fani Chatzopoulou, Konstantinos A. Kyritsis, Christos I. Papagiannopoulos, Eleftheria Galatou, Nikolaos Mittas, Nikoleta F. Theodoroula, Andreas S. Papazoglou, Efstratios Karagiannidis, Maria Chatzidimitriou, Anna Papa, Georgios Sianos, Lefteris Angelis, Dimitrios Chatzidimitriou, Ioannis S. Vizirianakis

    Published 2022-02-01
    Get full text
    Article
  6. 6
    Invariable Ribosome Stoichiometry During Murine Erythroid Differentiation: Implications for Understanding Ribosomopathies

    Invariable Ribosome Stoichiometry During Murine Erythroid Differentiation: Implications for Understanding Ribosomopathies by Christos I. Papagiannopoulos, Konstantinos A. Kyritsis, Konstantina Psatha, Konstantina Psatha, Konstantina Psatha, Konstantina Psatha, Dimitra Mavridou, Dimitra Mavridou, Fani Chatzopoulou, Fani Chatzopoulou, Georgia Orfanoudaki, Michalis Aivaliotis, Michalis Aivaliotis, Michalis Aivaliotis, Michalis Aivaliotis, Ioannis S. Vizirianakis, Ioannis S. Vizirianakis, Ioannis S. Vizirianakis

    Published 2022-02-01
    Get full text
    Article
  7. 7
    A Risk-Stratification Machine Learning Framework for the Prediction of Coronary Artery Disease Severity: Insights From the GESS Trial

    A Risk-Stratification Machine Learning Framework for the Prediction of Coronary Artery Disease Severity: Insights From the GESS Trial by Nikolaos Mittas, Fani Chatzopoulou, Fani Chatzopoulou, Konstantinos A. Kyritsis, Christos I. Papagiannopoulos, Nikoleta F. Theodoroula, Andreas S. Papazoglou, Efstratios Karagiannidis, Georgios Sofidis, Dimitrios V. Moysidis, Nikolaos Stalikas, Anna Papa, Dimitrios Chatzidimitriou, Georgios Sianos, Lefteris Angelis, Ioannis S. Vizirianakis, Ioannis S. Vizirianakis

    Published 2022-01-01
    Get full text
    Article
  8. 8
    Correction to: The GEnetic Syntax Score: a genetic risk assessment implementation tool grading the complexity of coronary artery disease—rationale and design of the GESS study

    Correction to: The GEnetic Syntax Score: a genetic risk assessment implementation tool grading the complexity of coronary artery disease—rationale and design of the GESS study by Ioannis S. Vizirianakis, Fani Chatzopoulou, Andreas S. Papazoglou, Efstratios Karagiannidis, Georgios Sofdis, Nikolaos Stalikas, Christos Stefopoulos, Konstantinos A. Kyritsis, Nikolaos Mittas, Nikoleta F. Theodoroula, Aggeliki Lampri, Eleni Mezarli, Anastasios Kartas, Dimitrios Chatzidimitriou, Anna Papa-Konidari, Eleftherios Angelis, Ηaralambos Karvounis, Georgios Sianos

    Published 2021-06-01
    Get full text
    Article

Search Tools: